What is RSV?
RSV is a common highly contagious respiratory virus causing infections of the lungs and breathing passages. RSV causes yearly outbreaks of respiratory infections in Canada from late fall to early spring.
RSV infection can happen at any age, and usually causes mild, cold-like symptoms. However, it can also cause more serious respiratory illness such as pneumonia, as well as make some illnesses and conditions worse in older adults. RSV is a major cause of hospitalization among adults over 60 years of age. Similar to influenza, RSV is a major cause of death among seniors.
What is RSV (AREXVY®) Vaccine?
AREXVY® is a non-live (in-activated) vaccine used to help protect adults 60 years and older from lower lung disease caused by respiratory syncytial virus (RSV). Studies show the vaccine to be more than 82% effective in preventing RSV and 94% effective in preventing severe RSV- associated lower lung infection.
Who should get AREXVY®?
All individuals 60 years of age and older.
Adults 60 years of age and older at increased risk of serious illness due to chronic health conditions (e.g., COPD, heart disease, diabetes, asthma, advanced lung/kidney disease).
Adults 60 years and older with weakened immune systems.
How is AREXVY given?
AREXVY® is given as an injection of 0.5 mL into a muscle (usually in the upper arm).
Will I need a booster?
No booster is currently recommended although data is still pending. At this point, we know a single dose provides at least 1.5 – 2 years protection.
Can I receive AREXVY® at the same time as my flu vaccine?
Yes, AREXVY® can be given at the same time as the seasonal flu vaccine.
What are the possible side effects from using AREXVY®?
AREXVY® vaccine is very safe. Side effects are generally mild to moderate, and do not last long (usually 1 to 2 days). Common side effects include pain, redness, and swelling at the injection site, as well as tiredness, headache, and muscle/joint pain. Tylenol® or Advil®/Motrin® can be taken for fever or soreness.
